The silence from the company at this point says a lot to me ... they are in negotiation mode (whatever form that might take)
key points...
1. resignation of investor director December 17 and no replacement
2. actual confirmation from company they are in negotiations with a number of parties
3. no updates this year (apart from statutory report)
I have cautioned myself not to short it ... might pay a price if I do.
Just my view - make up your own mind. I'm no expert.
DYOR
- Forums
- ASX - By Stock
- NEU
- pharmaceutical deals
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.43%
!
$16.39
pharmaceutical deals, page-24
-
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
